|
Q3 2021
Filed on Nov 12, 2021
|
42,252
|
$6.94 - $8.85
$293K - $374K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
55,027
|
$2.33 - $3.22
$128K - $177K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,650
|
$59.27 - $95.73
$157K - $254K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
15,056
|
$33.84 - $40.42
$509K - $609K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
6,615
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,311
|
$23.86 - $30.28
$246K - $312K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,726
|
$189.3 - $240.0
$327K - $414K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
12,108
|
$145.58 - $192.14
$1.76M - $2.33M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
7,217
|
$42.8 - $52.05
$309K - $376K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
36,459
|
$3.72 - $9.03
$136K - $329K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
45,907
|
$1.79 - $3.62
$82.2K - $166K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
23,895
|
$9.3 - $12.08
$222K - $289K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,200
|
$2.68 - $4.2
$27.3K - $42.8K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
14,406
|
$20.04 - $28.17
$289K - $406K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
20,759
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,329
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
18,675
|
$21.65 - $39.49
$404K - $737K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
40,626
|
$1.72 - $5.9
$69.9K - $240K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
4,027
|
$31.4 - $69.84
$126K - $281K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
31,096
|
$1.27 - $8.17
$39.5K - $254K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,179
|
$73.2 - $107.87
$233K - $343K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
10,097
|
$5.12 - $6.89
$51.7K - $69.6K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
1,289
|
$249.6 - $403.14
$322K - $520K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
11,460
|
$7.08 - $11.63
$81.1K - $133K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
7,976
|
$49.29 - $55.9
$393K - $446K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
12,851
|
$35.81 - $42.31
$460K - $544K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
9,823
|
$24.46 - $38.41
$240K - $377K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
25,219
|
N/A
|
|
Churchill Capital Corp Iv
|
Q3 2021
Filed on Nov 12, 2021
|
26,326
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
24,270
|
$4.69 - $7.77
$114K - $189K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,166
|
$155.75 - $178.79
$337K - $387K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
4,387
|
$52.0 - $120.21
$228K - $527K
|
|
Dicerna Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 12, 2021
|
5,585
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
24,702
|
$18.12 - $20.47
$448K - $506K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
20,526
|
$5.51 - $9.54
$113K - $196K
|
|
Foley Trasimene Acquistn Cor
|
Q3 2021
Filed on Nov 12, 2021
|
11,869
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
25,238
|
$3.59 - $5.0
$90.6K - $126K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
7,370
|
$49.69 - $56.15
$366K - $414K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
32,923
|
$24.67 - $51.48
$812K - $1.69M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
11,604
|
$29.18 - $36.55
$339K - $424K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,563
|
$62.85 - $71.47
$224K - $255K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
4,406
|
$37.85 - $58.44
$167K - $257K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
20,020
|
$7.9 - $21.51
$158K - $431K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,825
|
$65.76 - $90.65
$252K - $347K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
14,574
|
N/A
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
3,223
|
$68.7 - $78.4
$221K - $253K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
2,668
|
$132.37 - $176.78
$353K - $472K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
30,873
|
$40.5 - $66.99
$1.25M - $2.07M
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
9,868
|
$30.44 - $39.87
$300K - $393K
|
|
|
Q3 2021
Filed on Nov 12, 2021
|
13,625
|
N/A
|
|